Author:
Tegegnework Alebachew Zewdu,Aemiro Muluken Tessema,Bilchut Awraris Hailu,Mekuria Abinet Dagnaw,Yehualashet Sisay Shewasinad
Abstract
Abstract
Background
Tuberculosis preventive therapy is vital in caring for HIV-positive individuals, as it prevents the progression from latent tuberculosis infection to tuberculosis disease. The aim of the study is to assess the completion of tuberculosis preventive therapy and associated factors among clients receiving antiretroviral therapy in Debre Berhan town, Ethiopia, in 2022.
Method
Institutional based cross sectional study was conducted. Random sampling methods were used to select both study participants and health facilities. Both bivariate and multivariate logistic regression analyses were performed. P-values less than 0.05 were statistically significant.
Result
The study found that, 83% of participants were completed tuberculosis preventive therapy. Completed tuberculosis preventive therapy was associated with no adverse drug events, taking first-line ART, and good ART adherence.
Conclusion
According to the Ethiopian ART guidelines, the study found a low completion rate of tuberculosis preventive therapy among HIV-positive clients on antiretroviral therapy. Factors like no adverse drug events, first-line antiretroviral regimen, and good adherence were significantly associated with completing tuberculosis preventive therapy.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Nyathi S, Dlodlo RA, Satyanarayana S, Takarinda KC, Tweya H, Hove S, et al. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe. PLoS ONE. 2019;14(10):e0223076.
2. MOH. National Comprehensive TBLand TB/HIV training Manual. 2021.
3. Aboma M, Dida N. Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, Southwest Ethiopia: a retrospective study design. J Int Med Res. 2021;49(9):3000605211046133.
4. Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study. BMC Infect Dis. 2019;19(1):62.
5. FMoHo E. National consolidated guidelines for comprehensive HIV prevention, care and treatment. August;2018.